JNJ 全部观点

已加载 6 条观点条目,其中 1 条方向发生变化

在已加载记录中筛选
Schwab Network发布 2026-11-12
《The Big 3: JNJ, LLY, AAPL》
$JNJ看涨
AI 摘要 · JNJ 的趋势偏向上行;说话者计划在当前约 283 的水平附近,通过 12 月看涨期权价差(36 天后到期,283/270)入场,成本约 3 美元。若动能延续,他预计未来一个月内升向 300;若走弱,他更倾向于在 272-273 附近买入,而跌破 270 则将是颇具吸引力的长期入场点。

你的第一笔交易是Johnson & Johnson股票。你现在怎么看Johnson & Johnson?我们看到它们在今早的交易时段上涨。

You have Johnson & Johnson stock as your first trade here. How do you view Johnson & Johnson now? We see them rising in this morning's session.

事实上,这更像是一次几乎出乎意料的成功。我们从那些低点上涨了46%,那些低点基本上是52周的最低水平。我们在这里可以看到,近期高点285.48是在今天达到的。我们已经从那里回落了一点,但很明显,这是上行方向需要突破的水平。

这里这些较早的高点,也代表了一些价格波动,显示出突破281水平的一种困难。这也作为一个潜在的支撑区而突出。265也是我们近期的相对低点。

In fact, it's more like an almost unexpected success . We have risen 46% from those lows, which were largely the lowest levels in 52 weeks. What we can see here is that the recent highs of 285.48 were reached today.

We have fallen back a little from that, but it is clear that this is the level that needs to be surpassed in the upward direction. These older highs here, which also represented some price volatility , have shown a kind of difficulty in breaking through the 281 level.

This also stands out as a potential support zone. 265 is also our recent relative low.

Schwab Network发布 2026-10-29
《The Big 3: AAPL, JNJ, MMM》
$JNJ看涨
AI 摘要 · JNJ 是买入机会,也是长期核心持仓:财报后动能与医疗保健板块的防御性强势支撑进一步上行,周线趋势自2025年6月以来向上;突破275、继而突破278高点后,将打开290阻力位,唯一需警惕的是周线RSI出现看跌背离。

我们的第二选择是 Johnson & Johnson。尽管本季度录得重大亏损,其利润仍超出预期,并且仍在上涨。它们在今天的交易时段上涨。自公布财报以来它们一直在上涨。涨幅不算巨大,但它们是上涨的。

Dan,你现在如何看待 Johnson & Johnson?

Our second choice is Johnson & Johnson. Their profits have exceeded expectations despite incurring significant losses during the quarter, and they are still rising. They rose in today's session .

They have been rising since announcing their earnings. Not a huge increase, but they are positive. How do you view Johnson & Johnson now, Dan?

Verified Investing发布 2026-10-13
《What Is Implied Volatility? Vega Explained On A Live J&J Trade》
$JNJ看涨
AI 摘要 · 逆向做多 JNJ:财报后股价下跌 5%、跌破 250 后,预计将反弹至 250、260 和 270。资金流以看涨期权为主,但 IV rank 虽已从 80 降至 90 再降至约 62,仍不算便宜,需要更大的波动;2027 年 1 月 15 日到期的 260 看涨期权提供了更便宜的入场点。

我们决定放弃 Johnson & Johnson,因为看跌期权太贵了。Johnson & Johnson 公布了财报,而市场正在下跌。这没关系。

we decided to pass on Johnson & Johnson because the puts were too expensive. Johnson & Johnson posted their earnings and the market is falling. That is okay.

我的主要策略是逆向操作,今天我就打算这样来做 Johnson & Johnson。我会重新看同一个形态,看看能不能反过来操作,做点技术分析,然后今天找一个看涨期权。看看那个环境是否合适。

My primary is a contrarian desk and that's is how I'm going to play it Johnson & Johnson today. I'm going to revisit that same setup and see if we can flip the script and do some TA and um find it for a call today. See if that environment is fit.

Schwab Network发布 2026-10-13
《Tuesday's First Moves: WFC Mixed Earnings, JNJ Beat & Raise, DPZ Slides》
$JNJ中性
AI 摘要 · JNJ 利润和营收均超预期,但股价下跌约4%:制药业务靠 Tremfya 实现增长,而 Stelara 下滑;医疗科技业务仅增长2.5%至86亿美元,低于预期——归因于中东冲突、欧洲紧缩政策和中国价格压力,这也是该股走弱的原因。

我们来谈谈强生。在强生这边,情况更弱,股价承压,下跌约4%,尽管公司在净利润方面超出了预期。每股收益为2.59美元。分析师此前预期为每股2.53美元。营收也录得小幅增长,达到254亿美元。

市场此前预期强生为252.5亿美元,但他们指出,医疗科技板块会受到一些影响。那是最薄弱的环节,其中一部分是由于他们提到的地缘政治冲突。美国以外的销售基本持平。再次说明,总营收达到254亿美元,而预期为252.5亿美元。

Let's talk about Johnson & Johnson. At Johnson & Johnson, the picture is weaker , with shares under pressure and down about 4% despite the company beating expectations in net profit.

Earnings amounted to $2.59 per share . Analysts had expected $2.53 per share. Revenues also recorded a slight increase, reaching $25.4 billion. The market had been expecting $25.25 billion for Johnson & Johnson, but they noted there would be some impact on the medical technology sector .

That was the weakest point, and some of that is due to the geopolitical conflict they mentioned. Sales outside the United States were essentially stable . Once again, total revenues reached $25.4 billion, while the expected amount was $25.25 billion.

Verified Investing发布 2026-10-06
《Options 101 what are puts》
$JNJ看跌
AI 摘要 · JNJ 股价技术面动能偏空,目标位 245;但由于期权指标不利(隐含波动率高、delta 偏低、看跌/看涨比率偏多),该交易论点已被放弃。

好,各位。今天我在强生(Johnson & Johnson)上有一个很好的交易形态。代码是 JNJ。好,各位。既然说到了强生(Johnson & Johnson),我希望你们重点关注这一部分。

它在过去四天里一直承受抛售压力,今天在日内交易中略有反弹,转绿,但整体仍在下行。

Okay, guys. Today, I have a great setup on Johnson & Johnson. The code is JNJ. Okay, guys. With Johnson & Johnson in the picture, I want you to focus on this particular part. It has been experiencing selling pressure over the past four days, with a slight rebound today during daily trading, turning green, but it is heading downwards.

Stock Moe发布 2026-09-13
《CONGRESS OWNS THESE 10 STOCKS 🚨 The President Owns 5 Of Them Too (Best Stocks To Buy Now)》
$JNJ看涨
AI 摘要 · JNJ 是强力买入标的;医疗成本上升推动其表现,使其成为所讨论股票中表现最佳者。

Johnson and Johnson。我喜欢这只。这是个很好的选择。

Johnson and Johnson. I like that one. That's a good good play.

Johnson and Johnson,记得我跟你说过那是个好标的吗?到目前为止上涨 29.1%。医疗保健是那个人人都想要的选择。医疗保健。成本不断转嫁给消费者。它不断走高。Johnson and Johnson 就是,它就是稳赢。

Johnson and Johnson, remember I told you that was a good one? Up 29.1% so far. Healthcare is that one play that everybody wants. Healthcare. The costs keep getting passed on to consumers.

It keeps going higher. Johnson and Johnson's just it's a win.

这 10 只里今年表现最好的,也是关注度最低的那只。因为它不是科技股。

Uh the best performer this of the 10 this year and the name that gets the least attention. It's because it's not tech.

已经是最早的记录
其他股票的全部观点条目
把 $JNJ 加入我的股票30 天完整试用
开始试用